Silarus Therapeutics Receives $10,000,000 Series A Funding Round

  • Feed Type
  • Date
    9/23/2014
  • Company Name
    Silarus Therapeutics
  • Mailing Address
    Undisclosed La Jolla, CA 92037 USA
  • Company Description
    Silarus Therapeutics is developing therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. Erythroferrone is a recently-discovered hormone that regulates the iron supply for red blood cell production.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
  • Venture Investor